← Open Payments lookup

NARIMAN KONJKAVFARD: Open Payments

NPI 1619580032 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,419 in 76 payments from 10 companies in 2025. Trend: 2023 $230 · 2024 $1,141 · 2025 $1,419

Food & beverage: $1,419
CompanyPaymentsAmount
Alkermes, Inc.17$440
Teva Pharmaceuticals USA, Inc.12$208
ABBVIE INC.13$199
Otsuka America Pharmaceutical, Inc.11$164
Janssen Pharmaceuticals, Inc7$124
Neurocrine BioSciences, Inc.5$91
Lundbeck LLC5$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54
E.R. Squibb & Sons, L.L.C.2$37
Vanda Pharmaceuticals Inc.1$19

Products named: ARISTADA, VRAYLAR, LYBALVI, INVEGA SUSTENNA, UZEDY, REXULTI, ABILIFY ASIMTUFII, INGREZZA.

Industry payments across NJ — which companies pay providers there.